{{cart_num}}
My CartCAS：960358-79-6
Molecular Formula：C103H161N27O28
Molecular Weight：2225.54
Purity：≥95%
Appearance：Lyophilized powder
Storage：Store at -20℃，2 years.(Avoid freeze/thaw cycles)
Qty：
Size：
| Product Type | Peptides |
| CAS | 960358-79-6 |
| Sequence(1LC) | FNPSGPYQKKPVHEKKEVL |
| Sequence(3LC) | Phe-Asn-Pro-Ser-Gly-Pro-Tyr-Gln-Lys-Lys-Pro-Val-His-Glu-Lys-Lys-Glu-Val-Leu |
| Molecular Formula | C103H161N27O28 |
| Molecular Weight | 2225.54 |
| Purity | ≥95% |
| Appearance | Lyophilized powder |
| Solubility | H2O：≥ 50 mg/mL; *Ultrasonic solubilization; |
| Salt Form | Trifluoroacetate salt |
| Source | Synthetic |
| Storage | Store at -20℃，2 years.(Avoid freeze/thaw cycles) |
| Category/Label | Substrate and Enzyme Inhibitors |
| Background | CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1). CKLF1-C19 interacts with CCR4， and inhibits chemotaxis induced by both CKLF1 and CCL17. CKLF1-C19 can suppress allergic lung inflammation via inhibiting chemotaxis mediated by CCR3 and CCR4. |
| Reference | [1]. Tian L， et al. The CKLF1-C19 peptide attenuates allergic lung inflammation by inhibiting CCR3- and CCR4-mediated chemotaxis in a mouse model of asthma. Allergy. 2011 Feb;66(2):287-97. |
| Unit | Bottle |
| Specification | 1mg 5mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
